,10 Clinical trials conducted so far have not conclusively demonstrated effectiveness of either angiotensin-converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers (ARBs), or statins in reducing recurrent AF.11–13. This evidence concerns the gene ACE and atrial fibrillation.